Non-Small Cell Lung Cancer News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 12 articles
FDA approves Keytruda for adjuvant NSCLC treatment, expanding Merck’s lung cancer label
FDA approves Merck’s Keytruda for adjuvant NSCLC treatment
FDA approves Keytruda for adjuvant NSCLC, a Merck catalyst
FDA approves Keytruda adjuvant NSCLC use in early-stage lung cancer
FDA approves Keytruda adjuvant NSCLC use: what Merck investors should watch
Novo Nordisk CagriSema Phase 3 Obesity Results Signal Key Catalyst
Summit Therapeutics Ivonescimab Shows Overall Survival Benefit in Lung Cancer, ASCO 2026 Plenary Data Expected
AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
AACR 2024: Oncology News & Key Takeaways - Day 1
Revolution Medicines Presents Updated Zoldonrasib Phase 1 Data for KRAS G12D Lung Cancer at AACR 2026
FDA Approves Tecentriq for Extensive-Stage Small Cell Lung Cancer
FDA Grants Priority Review to Sotorasib for KRAS G12C NSCLC